Badea et al. reported that S100A4 was increased in pancreatic ductal adenocarcinoma (fold change = 4.37), and Pei et al. showed that S100A4 also overexpressed in Pancreatic carcinoma (fold change = 4.86) compared to normal samples. Here, S100A4 is linked to exocrine pancreatic carcinoma.